期刊文献+

高效液相色谱蒸发光散射检测法测定聚乙二醇干扰素α-2a注射液中游离聚乙二醇的含量 被引量:8

Quantitation of Free Polyethylene Glycol in PEGylated Interferon Alpha-2a Injection by HPLC-ELSD
原文传递
导出
摘要 建立聚乙二醇干扰素α-2a注射液中游离聚乙二醇含量的HPLC测定方法。以XBridge BEH 300 C4(4.6 mm×15.0 cm,3.5μm)色谱柱为固定相,以水-乙腈为流动相,梯度洗脱,流速1.0 mL/min,蒸发光散射检测器检测。游离聚乙二醇与聚乙二醇干扰素α-2a及其它辅料成分得到很好分离,聚乙二醇在20~100μg/mL范围内,进样量的对数值与峰面积的对数值之间有良好的线性关系(r=0.999),检测限和定量限分别为0.3μg和0.5μg,平均回收率为102.2%(RSD=2.1%)。结果表明,所建立的含量测定方法简便、快速、准确,可用于聚乙二醇干扰素α-2a注射液中游离聚乙二醇的含量测定。 A liquid chromatographic method was developed to quantitatively determine the free polyethylene glycol (PEG) in PEGy- lated interferon alpha-2a injection. This method separated and quantified free PEG upon an XBridge BEH 300 CA column (4.6 wm×15.0 cm,3.5 mm) using gradient elution of water-acetonitrile at the flow rate of 1.0 mL/min with an evaporative light scattering detector (ELSD). Drift tube temperature of the ELSD system was set to 90℃ and flow rate of nebulizing gas was 2.0 L/min. Free PEG was baseline separated from PEGylated interferon alpha-2a and other excipient ingredients. The logarithm of peak area from ELSD was linearly correlated to the logarithm of the injected quantity of PEG at the range of 0.4 - 2μg ( r =0. 999). The limit of detection (LOD) and limit of quantitation (LOQ) of the method were 0.3 μg and 0.5 i.Lg,respectively. The average recovery of PEG was 102.2% with RSD of 2.1% ( n = 6). The results show that the established method is simple, sensitive and accurate, and suggest applicability in the determination of free PEG in PEGylated interferon alpha-2a injection.
出处 《药物生物技术》 CAS 2014年第4期353-354,372,共3页 Pharmaceutical Biotechnology
基金 国家科技重大专项资助项目(No.2012ZX09304010)
关键词 聚乙二醇重组人干扰素α2a 游离聚乙二醇 高效液相色谱法 蒸发光散射检测 残留杂质 质量控制 PEGylated interferon alpha-2a, Free polyethylene glycol, High performance liquid chromatography, Evaporative lightscattering detection, Residual impurity, Quality control
  • 相关文献

参考文献5

二级参考文献45

  • 1WANGJun—zhi(王军志).The R&D and Quality Control of the Bio1ogical Technic Pharmaceutical(生物技术药物研究开发和质量控制)[M].Beijing(北京):Science Press(科学出版社),2002.121.
  • 2Winearh CC, Oliver DO, Pippard MJ, et al. Effect of human erythropoietin derived from recombinant DNA on anemic of patients mainmined by the chronic haemodialysis. Lancet, 1986,11 : 1175
  • 3Smith PK. Krohn RI, Hermanson, CT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem, 1985,150:76
  • 4GUORao—jun(郭尧君).The Experiment Technical of the Protein Electrophoresis(蛋白质电泳实验技术)[M].Beijing(北京):Science Press(科学出版社),1999.142.
  • 5.Chp(中国药典)(三部)[M].,2005Vo1Ⅲ.Appendix(附录)32.
  • 6Katre NV. Immunogenicity of recombinant IL -2 modifiedy covalent attachment of polyethylene glycol. J Immunol, 1990,44:209
  • 7Modi MW,Fulton JS,Buckmann DK,et al.Clearance of pegylated(40kD) interferon alfa-2a (PEGASYSTM)is primarily hepatic[J].Hepatology,2000,32(4):371a.
  • 8Reddy KR,Wright TL,Pockros PJ,et al.Efficacy and safety of pegylated(40kD) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C[J].Hepatology,2001,33(2):433.
  • 9Zeuzem S,Feinman SV,Rasenack J,et al.Peginterferon alfa-2a in patients with chronic hepatitis C[J].N Engl J Med,2000,343(23):1 666.
  • 10Fried MW,Shiffman ML,Reddy KR,et al.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J].N Engl J Med,2002,347(13):975.

共引文献13

同被引文献96

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部